Caffeine reduces dementia risk according to a huge study published today in JAMA. Investigators at Harvard University analyzed the caffeine intake of 131,821 individuals (86,606 females, and 45,215 males) with a follow-up…
New GLP-1 drug guidelines recently recommended by the World Health Organization (WHO) were reviewed in a JAMA article published online a few days ago. One major point? Global obesity rates have been…
Theo of Golden: A Review. Do you know of this impressive novel and its unusual history? How unusual? Well, it was initially self-published in 2023 and sold over 170, 000 copies before…
Are politics and medicine entwined? A report published this week in JAMA Forum suggests these two fields actually have connections. Are you scratching your head? The link between the two is revealed in…
Read The Color of North if you are awed by astonishing facts of life, such as the frog that freezes solid each winter and thaws and returns to life in the spring,…
Introducing Exerkines: The Magical Molecules of Exercise. Everyone knows that exercise improves health. That’s old news. Here’s something far more exciting. Scientists have demonstrated that our skeletal muscles do much more than just…
Selling faster than hotcakes: GLP-1 medications are flying off pharmacy shelves, and at fancy prices. Total spending in the U.S. for these drugs in 2023 (the latest year I found data for)…
Worried about AI? I am, and for reasons that should frighten everyone. There’s no doubt that Artificial Intelligence can be remarkably useful. You’ve probably used it. I have. I tinkered with it…
Our deluded HHS Secretary Kennedy is at it again. Earlier this week he fired all 17 members of the Center for Disease Control and Prevention’s vaccine advisory committee and will replace them…
HHS dumps successful vaccine developer. Do you remember Operation Warp Speed? During the first Trump administration that program led to the unbelievably fast development of Covid-19 vaccines by Moderna and Pfizer. Those…
Stay in Touch
An occasional note when Ken publishes something new. No spam. Reply to any email and Ken will take you off the list.
We’ll only use your email to send you Ken’s new posts. Privacy Policy
